SEARCH

SEARCH BY CITATION

References

  • 1
    Murphy SL, Xu J, Kochanek KD. Deaths: Final Data for 2010. National Vital Statistics Reports. Vol 61. No. 4. Hyattsville, MD: National Center for Health Statistics; 2013.
  • 2
    Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2010. Bethesda, MD: National Cancer Institute; 2013.
  • 3
    Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2328-2338.
  • 4
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 9 Regs Research Data, Nov. 2012 Sub (1973-2010) <Katrina/Rita Population Adjustment>-Linked To County Attributes-Total US, 1969-2011 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2013.
  • 5
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 18 Regs Research Data+Hurricane Katrina Impacted Louisiana Cases, Nov. 2012 Sub (2000-2010) <Katrina/Rita Population Adjustment>-Linked To County Attributes-Total US, 1969-2011 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2013.
  • 6
    Surveillance, Epidemiology and End Results (SEER) Program. SEER*Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence-CiNA Analytic File, 1995-2010, for NHIAv2 Origin, Custom File With County, ACS Facts and Figures Projection Project, North American Association of Central Cancer Registries. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2013.
  • 7
    Copeland G, Lake A, Firth R, et al. Cancer in North America: 2006-2010. Vol 1: Combined Cancer Incidence for the United States, Canada and North America. Springfield, IL: North American Association of Central Cancer Registries Inc; 2013.
  • 8
    Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, third edition. Cancer. 2005;103:1457-1467.
  • 9
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Mortality-All COD, Aggregated With County, Total US (1990-2010) <Katrina/Rita Population Adjustment>-Linked To County Attributes-Total US, 1969-2011 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2013. Released April 2013; underlying mortality data provided by National Center for Health Statistics.
  • 10
    Surveillance Research Program, National Cancer Institute SEER*Stat Software. Version 8.1.2. seer.cancer.gov/seerstat.
  • 11
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence- SEER 18 Regs Research Data+Hurricane Katrina Impacted Louisiana Cases, Nov. 2012 Sub (1973-2010 varying)-Linked To County Attributes-Total US, 1969-2011 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2013.
  • 12
    Zhu L, Pickle LW, Ghosh K, et al. Predicting US-and state-level cancer counts for the current calendar year: Part II: evaluation of spatiotemporal projection methods for incidence. Cancer. 2012;118:1100-1109.
  • 13
    Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9-29.
  • 14
    DevCan. Probability of Developing or Dying of Cancer Software. Version 6.7.0. Bethesda, MD: Statistical Research and Applications Branch, National Cancer Institute; 2013. srab.cancer.gov/devcan.
  • 15
    Pan IJ, Daniels JL, Zhu K. Poverty and childhood cancer incidence in the United States. Cancer Causes Control. 2010;21:1139-1145.
  • 16
    Barry MS, Auger N, Burrows S. Portrait of socio-economic inequality in childhood morbidity and mortality over time, Quebec, 1990-2005. J Paediatr Child Health. 2012;48:496-505.
  • 17
    Kroll ME, Stiller CA, Murphy MF, Carpenter LM. Childhood leukaemia and socioeconomic status in England and Wales 1976-2005: evidence of higher incidence in relatively affluent communities persists over time. Br J Cancer. 2011;105:1783-1787.
  • 18
    Bunin GR. Nongenetic causes of childhood cancers: evidence from international variation, time trends, and risk factor studies. Toxicol Appl Pharmacol. 2004;199:91-103.
  • 19
    Stiller CA, Parkin DM. Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull. 1996;52:682-703.
  • 20
    Bhatia S. Disparities in cancer outcomes: lessons learned from children with cancer. Pediatr Blood Cancer. 2011;56:994-1002.
  • 21
    Pui CH, Pei D, Pappo AS, et al. Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007. J Clin Oncol. 2012;30:2005-2012.
  • 22
    Linabery AM, Ross JA. Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer. 2008;113:2575-2596.
  • 23
    Steliarova-Foucher E, Stiller C, Kaatsch P, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet. 2004;364:2097-2105.
  • 24
    Kroll ME, Stiller CA, Richards S, Mitchell C, Carpenter LM. Evidence for under-diagnosis of childhood acute lymphoblastic leukaemia in poorer communities within Great Britain. Br J Cancer. 2012;106:1556-1559.
  • 25
    Smith MA, Freidlin B, Ries LA, Simon R. Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst. 1998;90:1269-1277.
  • 26
    Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation. Br J Radiol. 1997;70:130-139.
  • 27
    Mathews JD, Forsythe AV, Brady Z, et al. Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ. 2013;346:f2360.
  • 28
    Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012;380:499-505.
  • 29
    National Cancer Institute. Radiation Risks and Pediatric Computed Tomography (CT): A Guide for Health Care Providers. cancer.gov/cancertopics/causes/radiation/radiation-risks-pediatric-CT. Accessed November 20, 2013.
  • 30
    Bjorge T, Sorensen HT, Grotmol T, et al. Fetal growth and childhood cancer: a population-based study. Pediatrics. 2013;132:e1265-e1275.
  • 31
    Milne E, Greenop KR, Metayer C, et al. Fetal growth and childhood acute lymphoblastic leukemia: findings from the childhood leukemia international consortium. Int J Cancer. 2013;133:2968-2979.
  • 32
    O'Neill KA, Bunch KJ, Murphy MF. Intrauterine growth and childhood leukemia and lymphoma risk. Expert Rev Hematol. 2012;5:559-576.
  • 33
    Chokkalingam AP, Metayer C, Scelo G, et al. Fetal growth and body size genes and risk of childhood acute lymphoblastic leukemia. Cancer Causes Control. 2012;23:1577-1585.
  • 34
    MacLean J, Partap S, Reynolds P, Von Behren J, Fisher PG. Birth weight and order as risk factors for childhood central nervous system tumors. J Pediatr. 2010;157:450-455.
  • 35
    Rangel M, Cypriano M, de Martino Lee ML, et al. Leukemia, non-Hodgkin's lymphoma, and Wilms tumor in childhood: the role of birth weight. Eur J Pediatr. 2010;169:875-881.
  • 36
    Ognjanovic S, Carozza SE, Chow EJ, et al. Birth characteristics and the risk of childhood rhabdomyosarcoma based on histological subtype. Br J Cancer. 2010;102:227-231.
  • 37
    Roman E, Lightfoot T, Smith AG, et al. Childhood acute lymphoblastic leukaemia and birthweight: insights from a pooled analysis of case-control data from Germany, the United Kingdom and the United States. Eur J Cancer. 2013;49:1437-1447.
  • 38
    Cogliano VJ, Baan R, Straif K, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst. 2011;103:1827-1839.
  • 39
    Landrigan PJ, Goldman LR. Children's vulnerability to toxic chemicals: a challenge and opportunity to strengthen health and environmental policy. Health Aff (Millwood). 2011;30:842-850.
  • 40
    Dang-Tan T, Franco EL. Diagnosis delays in childhood cancer: a review. Cancer. 2007;110:703-713.
  • 41
    Margolin J, Rabin KR, Steuber CP, Poplack, DG. Acute lymphoblastic leukemia. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:518-565.
  • 42
    Caughey RW, Michels KB. Birth weight and childhood leukemia: a meta-analysis and review of the current evidence. Int J Cancer. 2009;124:2658-2670.
  • 43
    Urayama KY, Buffler PA, Gallagher ER, Ayoob JM, Ma X. A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia. Int J Epidemiol. 2010;39:718-732.
  • 44
    Urayama KY, Ma X, Selvin S, et al. Early life exposure to infections and risk of childhood acute lymphoblastic leukemia. Int J Cancer. 2011;128:1632-1643.
  • 45
    Eden T. Aetiology of childhood leukaemia. Cancer Treat Rev. 2010;36:286-297.
  • 46
    Kadan-Lottick NS, Ness KK, Bhatia S, Gurney JG. Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia. JAMA. 2003;290:2008-2014.
  • 47
    Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol. 2010;28:2625-2634.
  • 48
    Cooper TM, Hasle H, Smith FO. Acute myeloid leukemia, myeloproliferative and myelodysplastic disorders. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:566-610.
  • 49
    Hudson MM, Neglia JP, Woods WG, et al. Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies. Pediatr Blood Cancer. 2012;58:334-343.
  • 50
    Orgel E, Zung L, Ji L, Finklestein J, Feusner J, Freyer DR. Early cardiac outcomes following contemporary treatment for childhood acute myeloid leukemia: a North American perspective. Pediatr Blood Cancer. 2013;60:1528-1533.
  • 51
    Mulrooney DA, Dover DC, Li S, et al; Childhood Cancer Survivor Study. Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study. Cancer. 2008;112:2071-2079.
  • 52
    Metzger M, Krasin MJ, Hudson MM, Onciu M. Hodgkin lymphoma. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:638-662.
  • 53
    Swerdlow AJ, Cooke R, Bates A, et al. Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study. J Clin Oncol. 2012;30:2745-2752.
  • 54
    Travis LB, Hill D, Dores GM, et al. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst. 2005;97:1428-1437.
  • 55
    Saslow D, Boetes C, Burke W, et al; American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75-89.
  • 56
    Gross TG, Perkins SL. Malignant non-Hodgkin lymphomas in children. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:663-682.
  • 57
    Blaney SM, Haas-Kogan D, Poussaint Y, et al. Gliomas, ependymomas, and other nonembryonal tumors. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:717-771.
  • 58
    Packer RJ, Rorke-Adams LB, Lau CC, Taylor MD, Vezina G, Kun LE. Embryonal and pineal tumors. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:772-808.
  • 59
    Wilne SH, Dineen RA, Dommett RM, Chu TP, Walker DA. Identifying brain tumours in children and young adults. BMJ. 2013;347:f5844.
  • 60
    Black WC. Increasing incidence of childhood primary malignant brain tumors–enigma or no-brainer? J Natl Cancer Inst. 1998;90:1249-1251.
  • 61
    McKean-Cowdin R, Razavi P, Barrington-Trimis J, et al. Trends in childhood brain tumor incidence, 1973-2009. J Neurooncol. 2013;115:153-160.
  • 62
    Baldwin RT, Preston-Martin S. Epidemiology of brain tumors in childhood–a review. Toxicol Appl Pharmacol. 2004;199:118-131.
  • 63
    Huncharek M, Kupelnick B. A meta-analysis of maternal cured meat consumption during pregnancy and the risk of childhood brain tumors. Neuroepidemiology. 2004;23:78-84.
  • 64
    Bunin GR, Gallagher PR, Rorke-Adams LB, Robison LL, Cnaan A. Maternal supplement, micronutrient, and cured meat intake during pregnancy and risk of medulloblastoma during childhood: a children's oncology group study. Cancer Epidemiol Biomarkers Prev. 2006;15:1660-1667.
  • 65
    Pogoda JM, Preston-Martin S, Howe G, et al. An international case-control study of maternal diet during pregnancy and childhood brain tumor risk: a histology-specific analysis by food group. Ann Epidemiol. 2009;19:148-160.
  • 66
    Searles Nielsen S, Mueller BA, Preston-Martin S, Farin FM, Holly EA, McKean-Cowdin R. Childhood brain tumors and maternal cured meat consumption in pregnancy: differential effect by glutathione S-transferases. Cancer Epidemiol Biomarkers Prev. 2011;20:2413-2419.
  • 67
    Warren KE. Diffuse intrinsic pontine glioma: poised for progress. Front Oncol. 2012;2:205.
  • 68
    Armstrong GT. Long-term survivors of childhood central nervous system malignancies: the experience of the Childhood Cancer Survivor Study. Eur J Paediatr Neurol. 2010;14:298-303.
  • 69
    Brodeur GM, Hogarty MD, Mosse YP, Maris JM. Neuroblastoma. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:886-922.
  • 70
    Nickerson HJ, Matthay KK, Seeger RC, et al. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. J Clin Oncol. 2000;18:477-486.
  • 71
    Matthay KK, George RE, Yu AL. Promising therapeutic targets in neuroblastoma. Clin Cancer Res. 2012;18:2740-2753.
  • 72
    Montgomery BT, Kelalis PP, Blute ML, et al. Extended followup of bilateral Wilms tumor: results of the National Wilms Tumor Study. J Urol. 1991;146(2 pt 2):514-518.
  • 73
    National Cancer Institute. Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®). cancer.gov/cancertopics/pdq/treatment/wilms/HealthProfessional. Accessed December 3, 2013.
  • 74
    Breslow NE, Norris R, Norkool PA, et al. Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2003;21:4579-4585.
  • 75
    Scott RH, Stiller CA, Walker L, Rahman N. Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet. 2006;43:705-715.
  • 76
    Dumoucel S, Gauthier-Villars M, Stoppa-Lyonnet D, et al. Malformations, genetic abnormalities, and wilms tumor. Pediatr Blood Cancer. 2014;61:140-144.
  • 77
    Fernandez C, Geller JI, Ehrlich PF, et al. Renal tumors. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:861-885.
  • 78
    Wright KD, Green DM, Daw NC. Late effects of treatment for wilms tumor. Pediatr Hematol Oncol. 2009;26:407-413.
  • 79
    Breslow NE, Collins AJ, Ritchey ML, Grigoriev YA, Peterson SM, Green DM. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol. 2005;174:1972-1975.
  • 80
    Hurwitz RL, Shields CL, Shields JA, et al. Retinoblastoma. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:809-837.
  • 81
    National Cancer Institute. Retinoblastoma Treatment (PDQ®). cancer.gov/cancertopics/pdq/treatment/retinoblastoma/HealthProfessional. Accessed December 3, 2013.
  • 82
    Chintagumpala M, Chevez-Barrios P, Paysse EA, Plon SE, Hurwitz R. Retinoblastoma: review of current management. Oncologist. 2007;12:1237-1246.
  • 83
    Houston SK, Murray TG, Wolfe SQ, Fernandes CE. Current update on retinoblastoma. Int Ophthalmol Clin. 2011;51:77-91.
  • 84
    Kleinerman RA, Yu CL, Little MP, et al. Variation of second cancer risk by family history of retinoblastoma among long-term survivors. J Clin Oncol. 2012;30:950-957.
  • 85
    Gorlick R, Bielack S, Teot L, Meyer J, Randall RL, Neyssa M. Osteosarcoma: biology, diagnosis, treatment, and remaining challenges. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:1015-1044.
  • 86
    Mirabello L, Pfeiffer R, Murphy G, et al. Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes Control. 2011;22:899-908.
  • 87
    Kaste SC, Pratt CB, Cain AM, Jones-Wallace DJ, Rao BN. Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: imaging features. Cancer. 1999;86:1602-1608.
  • 88
    Delatte O, Zucman J, Melot T, et al. The Ewing family of tumors–a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med. 1994;331:294-299.
  • 89
    Esiashvili N, Goodman M, Marcus RB Jr. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. J Pediatr Hematol Oncol. 2008;30:425-430.
  • 90
    Ginsberg JP, Goodman P, Leisenring W, et al. Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study. J Natl Cancer Inst. 2010;102:1272-1283.
  • 91
    Gurney JG, Young JL, Roffers SF, Smith MA, Bunin GR. Soft tissue sarcomas. In: Ries LAG, Smith MA, Gurney JG, et al, eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute, SEER Program; 1999.
  • 92
    Davicioni E, Anderson MJ, Finckenstein FG, et al. Molecular classification of rhabdomyosarcoma–genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group. Am J Pathol. 2009;174:550-564.
  • 93
    Rudzinski ER. Histology and fusion status in rhabdomyosarcoma. Am Soc Clin Oncol Educ Book. 2013:425-428.
  • 94
    McDowell HP. Update on childhood rhabdomyosarcoma. Arch Dis Child. 2003;88:354-357.
  • 95
    Linardic CM. PAX3-FOXO1 fusion gene in rhabdomyosarcoma. Cancer Lett. 2008;270:10-18.
  • 96
    Marshall AD, Grosveld GC. Alveolar rhabdomyosarcoma-the molecular drivers of PAX3/7-FOXO1-induced tumorigenesis. Skelet Muscle. 2012;2:25.
  • 97
    Xia SJ, Pressey JG, Barr FG. Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol Ther. 2002;1:97-104.
  • 98
    Wexler LH, Meyer WH, Helman LJ. Rhabdomyosarcoma. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:923-953.
  • 99
    Arndt CA, Rose PS, Folpe AL, Laack NN. Common musculoskeletal tumors of childhood and adolescence. Mayo Clin Proc. 2012;87:475-487.
  • 100
    Olson TA, Schneider DT, Perlman EJ. Germ cell tumors. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:1045-1067.
  • 101
    De Backer A, Madern GC, Oosterhuis JW, Hakvoort-Cammel FG, Hazebroek FW. Ovarian germ cell tumors in children: a clinical study of 66 patients. Pediatr Blood Cancer. 2006;46:459-464.
  • 102
    Hastings CA, Torkildson JC, Agrawal AK. Germ cell tumors. In: Handbook of Pediatric Hematology and Oncology: Children's Hospital and Research Center Oakland. 2nd ed. Chichester, UK: John Wiley and Sons, Ltd; 2012:193-199.
  • 103
    Milose JC, Filson CP, Weizer AZ, Hafez KS, Montgomery JS. Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance. Open Access J Urol. 2011;4:1-8.
  • 104
    Cost NG, Lubahn JD, Adibi M, et al. A comparison of pediatric, adolescent, and adult testicular germ cell malignancy [published online ahead of print September 17, 2013]. Pediatr Blood Cancer. doi: 10.1002/pbc.24773.
  • 105
    Krane EJ, Casillas J, Zeltzer L. Pain and symptom management. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:1256-1287.
  • 106
    Oppenheim D. The child's subjective experience of cancer and the relationship with parents and caregivers. In: Kreitler S, Ben Arush MW, eds. Psychosocial Aspects of Pediatric Oncology. Chichester, UK: John Wiley and Sons, Ltd; 2004:109-138.
  • 107
    Wiener LS, Hersh SP, Alderfer MA. Psychiatric and psychosocial support for the child and family. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010:1322-1346.
  • 108
    Bryant R. Managing side effects of childhood cancer treatment. J Pediatr Nurs. 2003;18:113-125.
  • 109
    Skeen JE, Wesbter ML. Speaking to children about serious matters. In: Kreitler S, Ben Arush MW, eds. Psychosocial Aspects of Pediatric Oncology. Chichester, UK: John Wiley and Sons, Ltd; 2004:281-312.
  • 110
    Wolfe J, Tournay A, Zeltzer L. Palliative care for children with advanced cancer. In: Kreitler S, Ben Arush MW, eds. Psychosocial Aspects of Pediatric Oncology. Chichester, UK: John Wiley and Sons, Ltd; 2004:45-70.
  • 111
    Postovsky S, Ben Arush MW. Care of a child dying of cancer. In: Kreitler S, Ben Arush MW, eds. Psychosocial Aspects of Pediatric Oncology. Chichester, UK: John Wiley and Sons, Ltd; 2004:93-108.
  • 112
    National Cancer Policy Board, Institute of Medicine, National Research Council of the National Academies; Hewitt M, Weiner SL, Simone JV, eds. Childhood Cancer Survivorship: Improving Care and Quality of Life. Washington, DC: National Academies Press; 2003.
  • 113
    Singer S, Gianinazzi ME, Hohn A, Kuehni CE, Michel G. General practitioner involvement in follow-up of childhood cancer survivors: a systematic review. Pediatr Blood Cancer. 2013;60:1565-1573.
  • 114
    Kurt BA, Armstrong GT, Cash DK, et al. Primary care management of the childhood cancer survivor. J Pediatr. 2008;152:458-466.
  • 115
    Children's Oncology Group. Long-term Follow-Up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancers. Version 3.0. survivorshipguidelines.org Accessed November 18, 2013.
  • 116
    Shankar SM, Marina N, Hudson MM, et al; Cardiovascular Disease Task Force of the Children's Oncology Group. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group. Pediatrics. 2008;121:e387-e396.
  • 117
    Wasilewski-Masker K, Liu Q, Yasui Y, et al. Late recurrence in pediatric cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2009;101:1709-1720.
  • 118
    Meadows AT, Friedman DL, Neglia JP, et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27:2356-2362.
  • 119
    Henderson TO, Friedman DL, Meadows AT. Childhood cancer survivors: transition to adult-focused risk-based care. Pediatrics. 2010;126:129-136.
  • 120
    Friedman DL, Whitton J, Leisenring W, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2010;102:1083-1095.
  • 121
    Inskip PD, Robison LL, Stovall M, et al. Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol. 2009;27:3901-3907.
  • 122
    Henderson TO, Amsterdam A, Bhatia S, et al. Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med. 2010;152:444-455; W144-W154.
  • 123
    Yahalom J. Evidence-based breast cancer screening guidelines for women who received chest irradiation at a young age. J Clin Oncol. 2013;31:2240-2242.
  • 124
    Hudson MM, Ness KK, Gurney JG, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013;309:2371-2381.
  • 125
    Lipshultz SE, Adams MJ, Colan SD, et al. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation. 2013;128:1927-1995.
  • 126
    American Cancer Society. Global Cancer Facts & Figures. 2nd ed. Atlanta, GA: American Cancer Society; 2011.
  • 127
    Ribeiro R, Pui CH. Treatment of acute lymphoblastic leukemia in low- and middle-income countries: challenges and opportunities. Leuk Lymphoma. 2008;49:373-376.
  • 128
    Hesseling P, Molyneux E, Kamiza S, Israels T, Broadhead R. Endemic Burkitt lymphoma: a 28-day treatment schedule with cyclophosphamide and intrathecal methotrexate. Ann Trop Paediatr. 2009;29:29-34.
  • 129
    Bhakta N, Martiniuk AL, Gupta S, Howard SC. The cost effectiveness of treating paediatric cancer in low-income and middle-income countries: a case-study approach using acute lymphocytic leukaemia in Brazil and Burkitt lymphoma in Malawi. Arch Dis Child. 2013;98:155-160.
  • 130
    Dimaras H, Dimba EA, Gallie BL. Challenging the global retinoblastoma survival disparity through a collaborative research effort. Br J Ophthalmol. 2010;94:1415-1416.
  • 131
    Hopkins A, Burns E, Eden T. International twinning partnerships: an effective method of improving diagnosis, treatment and care for children with cancer in low-middle income countries. J Cancer Policy. 2013;1:e8-e19.
  • 132
    Green DM, Kun LE, Matthay KK, et al. Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors. Pediatr Blood Cancer. 2013;60:1083-1094.
  • 133
    Kremer LC, Mulder RL, Oeffinger KC, et al; International Late Effects of Childhood Cancer Guideline Harmonization Group. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer. 2013;60:543-549.
  • 134
    Nathan PC, Ford JS, Henderson TO, et al. Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort. J Clin Oncol. 2009;27:2363-2373.
  • 135
    Green DM, Cox CL, Zhu L, et al. Risk factors for obesity in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2012;30:246-255.
  • 136
    Armstrong GT, Oeffinger KC, Chen Y, et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013;31:3673-3680.
  • 137
    Anderson LM. Environmental genotoxicants/carcinogens and childhood cancer: bridgeable gaps in scientific knowledge. Mutat Res. 2006;608:136-156.
  • 138
    Miller JW, Beresford SA, Neuhouser ML, et al. Homocysteine, cysteine, and risk of incident colorectal cancer in the Women's Health Initiative observational cohort. Am J Clin Nutr. 2013;97:827-834.